OrbiMed’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-612,700
| Closed | -$68.6M | – | 160 |
|
|
2021
Q3 | $68.6M | Buy |
612,700
+93,700
| +18% | +$10.5M | 0.75% | 42 |
|
|
2021
Q2 | $84M | Sell |
519,000
-33,500
| -6% | -$5.42M | 0.85% | 39 |
|
|
2021
Q1 | $67.3M | Buy |
552,500
+100,700
| +22% | +$12.3M | 0.63% | 47 |
|
|
2020
Q4 | $69.2M | Sell |
451,800
-178,204
| -28% | -$27.3M | 0.61% | 46 |
|
|
2020
Q3 | $52.7M | Sell |
630,004
-67,520
| -10% | -$5.65M | 0.66% | 45 |
|
|
2020
Q2 | $51.3M | Buy |
697,524
+146,324
| +27% | +$10.8M | 0.72% | 45 |
|
|
2020
Q1 | $23.4M | Sell |
551,200
-215,178
| -28% | -$9.13M | 0.39% | 60 |
|
|
2019
Q4 | $46.7M | Buy |
766,378
+249,978
| +48% | +$15.2M | 0.67% | 47 |
|
|
2019
Q3 | $21.2M | Buy |
+516,400
| New | +$21.2M | 0.4% | 60 |
|
|
2018
Q4 | – | Sell |
-496,200
| Closed | -$22M | – | 130 |
|
|
2018
Q3 | $22M | Hold |
496,200
| – | – | 0.27% | 82 |
|
|
2018
Q2 | $29.2M | Buy |
496,200
+391,799
| +375% | +$23M | 0.35% | 68 |
|
|
2018
Q1 | $4.77M | Buy |
+104,401
| New | +$4.77M | 0.06% | 115 |
|
|
2017
Q4 | – | Sell |
-372,191
| Closed | -$6.65M | – | 131 |
|
|
2017
Q3 | $6.65M | Hold |
372,191
| – | – | 0.06% | 113 |
|
|
2017
Q2 | $5.96M | Hold |
372,191
| – | – | 0.06% | 107 |
|
|
2017
Q1 | $8.1M | Hold |
372,191
| – | – | 0.09% | 102 |
|
|
2016
Q4 | $7.54M | Buy |
+372,191
| New | +$7.54M | 0.1% | 96 |
|